Chromadex-Bruker team up allows in-house raw material testing
A new supplement testing technology would allow manufacturers to obtain in-house capabilities to perform raw material identity testing and determine if any adulteration has taken place.
A new supplement testing technology would allow manufacturers to obtain in-house capabilities to perform raw material identity testing and determine if any adulteration has taken place.
Co-developed by ChromaDex Corporation and Bruker Optics Inc., the test will initially focus on the near infrared spectrometer (NIR) technology created by Bruker Optics, and uses the phytochemical and botanical reference standard capabilities of ChromaDex.
Dietary supplement manufacturers will be able to obtain the in-house capabilities of a contract laboratory without the associated start-up costs, said the companies, and can be accomplished by existing staff utilizing a Bruker NIR unit located in the manufacturer's facility.
The issue
Deliberate adulteration of products continues to be an issue for the dietary supplements industry and can be either economically motivated adulteration (EMA) or to intensify a specific pharmacological effect. The GMP regulations are widely accepted as a big step in the right direction: The 2007 GMP regulations place the onus on product manufacturers to ensure the quality of their raw materials is sufficient.
Adulteration does still occur, however, and notable examples include adulteration with erectile dysfunction drugs, weight-loss drugs, melamine, and steroid compounds.
"This novel approach to quality control testing will enable manufacturers to save time and money, while at the same time providing a robust solution to quality needs that will greatly benefit the industry," said Frank Jaksch, CEO and co-founder of ChromaDex Inc.
"We have chosen to collaborate with Bruker on this because we believe the testing platform they have developed, when coupled with our products and knowledge, will prove to be the solution the market has long been seeking,” added Jaksch.
“This collaboration has the potential to significantly advance dietary supplement testing at the manufacturer's location,” said John Richmond, vice president of Bruker Optics Inc.
Both companies said they anticipate extending the relationship to include other Bruker analytical technologies.
Source: ChromaDex Inc.
All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
